Sep 3, 2026 04:10AM
Aug 20, 2026 06:50AM
Aug 20, 2026 05:04AM
Aug 4, 2026 04:05PM
May 5, 2026 04:01PM
Apr 2, 2026 12:00PM
Apr 2, 2026 10:46AM Leerink Partners on Ultragenyx Pharma (RARE): FDA BLA acceptance positions co for two approvals, $150M oppty
Apr 2, 2026 08:31AM
Apr 2, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 12, 2026 04:01PM
Feb 3, 2026 06:44AM
Jan 30, 2026 08:31AM Ultragenyx resubmits gene therapy application for rare brain disease
Jan 30, 2026 08:30AM
Jan 12, 2026 07:31AM
Jan 12, 2026 07:30AM
Jun 23, 2025 10:33AM
May 6, 2025 04:01PM
Feb 19, 2025 07:13AM
Feb 18, 2025 08:07AM Ultragenyx Pharma (RARE) Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A
Feb 18, 2025 08:00AM
Feb 18, 2025 06:52AM
Feb 14, 2025 06:57AM
Feb 13, 2025 04:01PM
Feb 5, 2025 08:00AM
Feb 5, 2025 08:00AM
Jan 13, 2025 05:22AM Goldman Sachs on Ultragenyx Pharma (RARE): 'we remain constructive'
Jan 12, 2025 11:00AM
May 15, 2023 09:10AM
May 15, 2023 09:08AM
Jul 1, 2020 08:11AM
May 6, 2020 04:01PM
May 6, 2020 04:01PM
Feb 27, 2020 08:06AM Ultragenyx Pharma (RARE), Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for Crysvita for TIO
Feb 27, 2020 08:00AM
Feb 27, 2020 08:00AM
Feb 13, 2020 04:01PM
Feb 13, 2020 04:01PM
Jan 13, 2020 08:20AM
Jan 13, 2020 08:10AM
Jan 13, 2020 08:10AM Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance
Nov 5, 2019 04:01PM
Nov 5, 2019 04:01PM
Oct 14, 2019 08:32AM
Oct 14, 2019 08:30AM
Oct 14, 2019 08:30AM
Feb 23, 2018 08:07AM
Feb 23, 2018 08:00AM Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorization in Europe for the Treatment of X–Linked Hypophosphatemia in Children
Feb 23, 2018 08:00AM

15,747 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All